Hepatitis B
Hepatitis B is a viral infection that attacks the liver, potentially leading to chronic liver disease, liver failure, or liver cancer. It can be transmitted through contact with infectious body fluids.
HIV and Hepatitis B: Bepirovirsen Treatment Study
We are studying a new treatment for people living with both HIV and chronic Hepatitis B. The trial aims to see if bepirovirsen can help reduce the Hepatitis B virus in patients already receiving antiretroviral therapy.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you currently taking any immunosuppressing drugs like prednisone or other steroids?
- Do you have a history of liver cirrhosis or liver cancer?
- Are you currently taking blood thinners like Warfarin, Eliquis, or Xarelto?
- Have you had any major surgery in the past 3 months?
- Do you have untreated syphilis infection?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Bepirovirsen Sodium
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hopital Europeen Marseille
Service Médecine Interne - Maladies Infectieuses
Marseille, France
Groupe Hospitalier Du Sud Ile De France
Service des maladies infectieuses et tropicales
Melun, France
Centre Hospitalier Universitaire De Montpellier
Hôpital Saint Eloi - Service Hépato-Gastro-Entérologie
Montpellier, France
Sponsor: Glaxosmithkline Research & Development Limited
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.